About
Technology
Issues
FAQ
Links
Official Page
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.